Rocket


News + Filings
Transactions



Chin Mark

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
10/01/2023Harpoon Therapeutics, Inc.HARPGrantCommon Stock3k$0.00$0 10/01/2023
07/01/2023Harpoon Therapeutics, Inc.HARPGrantCommon Stock18.7k$0.00$0 07/01/2023
06/15/2023Iterum Therapeutics plcITRMExerciseRestricted Share Units15.9k$0.00$0 06/15/2023
06/09/2023Disc Medicine, Inc. GrantStock Option (Right to Buy)7.1k$45.69$326k 06/09/2023
04/01/2023Harpoon Therapeutics, Inc.HARPGrantCommon Stock18.3k$0.00$0 04/01/2023
12/29/2022Disc Medicine, Inc. GrantStock Option (Right to Buy)7k$13.50$94.5k 12/29/2022
06/23/2022Iterum Therapeutics plcITRMExerciseRestricted Share Units36.8k$0.00$0 06/23/2022
06/22/2022Harpoon Therapeutics, Inc.HARPGrantDirector Stock Option (Right to Buy)10.2k$2.01$20.4k 06/22/2022
06/22/2022Harpoon Therapeutics, Inc.HARPGrantDirector Stock Option (Right to Buy)32.1k$2.01$64.6k 06/22/2022
06/15/2022Iterum Therapeutics plcITRMGrantRestricted Share Units237.8k$0.01$2.4k 06/15/2022
06/02/2022Enliven Therapeutics, Inc.IMRAGrantStock Options (Right to Buy)8.5k$1.07$9.1k 06/02/2022
04/21/2022Pyxis Oncology, Inc.PYXSSaleCommon Stock1.7M$3.05$5.3MSee footnote04/21/2022
03/31/2022Pyxis Oncology, Inc.PYXSGrantCommon Stock66.8k$0.00$0 03/31/2022
10/13/2021Pyxis Oncology, Inc.PYXSConversionSeries B Convertible Preferred Stock9.1M$0.00$0See footnote10/13/2021
10/13/2021Pyxis Oncology, Inc.PYXSPurchaseCommon Stock312.5k$16.00$5MSee footnote10/13/2021
10/13/2021Pyxis Oncology, Inc.PYXSConversionCommon Stock1.4M$0.00$0See footnote10/13/2021
10/07/2021Pyxis Oncology, Inc.PYXSGrantStock Option (Right to buy)42.2k$16.00$675.1k 10/07/2021
07/16/2021Enliven Therapeutics, Inc.IMRAPurchaseCommon Stock1.3M$6.00$8MBy entities affiliated with Arix Bioscience plc07/16/2021
06/29/2021Enliven Therapeutics, Inc.IMRAGrantStock Options (Right to Buy)7.7k$8.12$62.8k 06/29/2021
06/23/2021Iterum Therapeutics plcITRMGrantRestricted Stock Units36.8k$0.00$0 06/23/2021
05/04/2021Harpoon Therapeutics, Inc.HARPGrantDirector Stock Option (Right to Buy)2.4k$0.00$0 05/04/2021
05/04/2021Harpoon Therapeutics, Inc.HARPGrantDirector Stock Option (Right to Buy)10.2k$0.00$0 05/04/2021
05/04/2021Harpoon Therapeutics, Inc.HARPGrantDirector Stock Option (Right to Buy)10.2k$22.50$228.8k 05/04/2021
05/04/2021Harpoon Therapeutics, Inc.HARPGrantDirector Stock Option (Right to Buy)3k$22.50$67.9k 05/04/2021
07/28/2020Iterum Therapeutics plcITRMOther (disposition)Ordinary Shares11.9k$0.00$0 07/28/2020
07/01/2020Iterum Therapeutics plcITRMExerciseRestricted Stock Units5.7k$0.00$0 07/01/2020
05/28/2020Harpoon Therapeutics, Inc.HARPGrantDirector Stock Option (Right to Buy)3k$20.59$62.1k 05/28/2020
05/28/2020Harpoon Therapeutics, Inc.HARPGrantDirector Stock Option (Right to Buy)10.2k$20.59$209.3k 05/28/2020
04/07/2020Iterum Therapeutics plcITRMOther (disposition)6.500% Exchangeable Senior Subordinated Note due 20250$0.00$0By Arix Bioscience Holdings Ltd.04/07/2020
04/07/2020Iterum Therapeutics plcITRMOther (disposition)Ordinary Shares1.1M$0.00$0By Arix Bioscience Holdings Ltd.04/07/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionCommon Stock1.4M$0.00$0By entities affiliated with Arix Bioscience plc03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAPurchaseCommon Stock187.5k$16.00$3MBy entities affiliated with Arix Bioscience plc03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAConversionSeries B Preferred Stock8.6M$0.00$0By entities affiliated with Arix Bioscience plc03/16/2020
03/16/2020Enliven Therapeutics, Inc.IMRAGrantStock Option (right to buy)15.5k$16.00$247.3k 03/16/2020
01/21/2020Iterum Therapeutics plcITRMGrant6.500% Exchangeable Senior Subordinated Note due 20250$1,900,000.00$0By Arix Bioscience Holdings Ltd.01/21/2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy